Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-08 10:52 am Sale | 13G | Revolution Medicines Inc. RVMD | WELLINGTON MANAGEMENT GROUP LLP | 11,401,394 6.830% | -3,480,692 (-23.39%) | View |
| 2024-02-14 6:30 pm Sale | 13G | Revolution Medicines Inc. RVMD | EcoR1 Capital LLC | 132,579 0.100% | -7,066,121 (-98.16%) | View |
| 2024-02-14 09:26 am Sale | 13G | Revolution Medicines Inc. RVMD | BIOTECHNOLOGY VALUE FUND L P | 5,981,212 3.600% | -1,574,376 (-20.84%) | View |
| 2024-02-13 5:13 pm Purchase | 13G | Revolution Medicines Inc. RVMD | VANGUARD GROUP INC | 14,634,391 8.930% | 7,072,481 (+93.53%) | View |
| 2024-02-13 06:06 am Purchase | 13G | Revolution Medicines Inc. RVMD | BB BIOTECH AG | 5,046,700 3.100% | 269,138 (+5.63%) | View |
| 2024-02-12 5:11 pm Sale | 13G | Revolution Medicines Inc. RVMD | Farallon Capital Partners L.P. | 6,750,204 4.100% | -12,276 (-0.18%) | View |
| 2024-02-09 5:22 pm Sale | 13G | Revolution Medicines Inc. RVMD | COLUMN GROUP III LP | 46 0.000% | -3,347,153 (-100.00%) | View |
| 2024-02-08 10:17 am Purchase | 13G | Revolution Medicines Inc. RVMD | WELLINGTON MANAGEMENT GROUP LLP | 14,882,086 9.090% | 662,656 (+4.66%) | View |
| 2024-01-26 11:49 am Purchase | 13G | Revolution Medicines Inc. RVMD | BlackRock Inc. BLK | 12,954,314 7.900% | 6,378,368 (+97.00%) | View |
| 2023-11-09 5:18 pm Purchase | 13G | Revolution Medicines Inc. RVMD | Farallon Capital Partners L.P. | 6,762,480 6.200% | 6,762,480 (New Position) | View |
| 2023-11-09 1:26 pm Purchase | 13G | Revolution Medicines Inc. RVMD | WELLINGTON MANAGEMENT GROUP LLP | 14,219,430 12.990% | 5,345,456 (+60.24%) | View |
| 2023-06-30 4:33 pm Purchase | 13G | Revolution Medicines Inc. RVMD | BIOTECHNOLOGY VALUE FUND L P | 7,555,588 7.100% | 5,745,039 (+317.31%) | View |
| 2023-06-16 4:12 pm Purchase | 13G | Revolution Medicines Inc. RVMD | EcoR1 Capital LLC | 7,198,700 6.800% | 2,720,650 (+60.76%) | View |
| 2023-02-14 4:15 pm Purchase | 13G | Revolution Medicines Inc. RVMD | BB BIOTECH AG | 4,777,562 5.400% | 175,000 (+3.80%) | View |
| 2023-02-14 4:03 pm Sale | 13G | Revolution Medicines Inc. RVMD | Third Rock Ventures III L.P. | 1,939,692 2.200% | -3,713,598 (-65.69%) | View |
| 2023-02-13 4:23 pm Unchanged | 13G | Revolution Medicines Inc. RVMD | COLUMN GROUP III LP | 3,347,199 3.800% | 0 (Unchanged) | View |
| 2023-02-09 11:30 am Purchase | 13G | Revolution Medicines Inc. RVMD | VANGUARD GROUP INC | 7,561,910 8.520% | 1,262,301 (+20.04%) | View |
| 2023-02-06 2:56 pm Sale | 13G | Revolution Medicines Inc. RVMD | WELLINGTON MANAGEMENT GROUP LLP | 8,873,974 9.990% | -62,495 (-0.70%) | View |
| 2023-01-31 1:58 pm Purchase | 13G | Revolution Medicines Inc. RVMD | BlackRock Inc. BLK | 6,575,946 7.400% | 1,100,727 (+20.10%) | View |
| 2023-01-23 12:14 pm Purchase | 13G | Revolution Medicines Inc. RVMD | EcoR1 Capital LLC | 4,478,050 5.000% | 199,981 (+4.67%) | View |